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While hepatocytes rarely undergo proliferation in normal livers, they quickly induce proliferation in response to loss of liver mass
by toxin or inﬂammation-induced hepatocyte injury, trauma, or surgical resection, leading to a restoration of liver mass to its
original size. Recent studies suggest that Toll-like receptor (TLR) signaling participates in this regenerative response. Myeloid
diﬀerentiation factor (MyD88), a common adaptor molecule in the TLR, IL-1 and IL-18 receptor signaling, plays a key role, at
least, in the early phase of liver regeneration. Currently, deﬁnite ligands which bind to TLRs and initiate this process are still
unclear. TLRs stimulated by their corresponding ligands, as well as tumor necrosis factor (TNF) receptors (TNFRs), can activate
downstream signal molecules, including transcription factor nuclear factor (NF)-κB and c-Jun N-terminal kinase (JNK). Previous
studies have revealed the important role of TNF receptor signaling, NF-κB, and JNK in liver regeneration by using hepatocyte-
speciﬁc gene-modiﬁed animals. This review will summarize the current knowledge of TLR signaling and their related molecules in
liver regeneration. We will also discuss whether modulating these factors may become new therapeutic strategies to promote liver
regeneration in various clinical situations.
1.Introduction
The liver is a unique organ that has a great ability to
regenerate by itself [1, 2]. After loss of considerable liver
mass, orchestrated biological responses are quickly activated
to restore the loss of liver mass by hepatocyte regenera-
tion until the liver reaches its original size [1–4]. In this
regenerative process, mainly mature hepatocytes proliferate
by the stimulation of the regenerative factors released
from parenchymal and nonparenchymal liver cells. However,
liver failure and massive hepatocyte death (apoptosis and
necrosis) in ﬂuminant hepatitis could stimulate liver stem
cells (or oval cells), which contribute to liver regeneration
[5]. Suppressed proliferative ability in mature hepatocytes
caused by hepato-toxin exposures, hepatitis B or C virus
infection, or excessive lipid accumulation in alcoholic steato-
hepatitis (ASH), and nonalcoholic steatohepatitis (NASH),
also induces the activation of liver stem cells leading to
liver regeneration [5]. Because liver injuries induced by
inﬂammation or ischemia/reperfusion and their relation to
toll-like receptors (TLRs) are being discussed elsewhere in
this issue, we will focus on the role of TLR signaling in
liver regeneration after partial hepatectomy (PH), which is
a pure hepatic regeneration model. We will further discuss
thepotentialroleofTLRsandsubsequentsignalingpathways
that activate nuclear factor (NF)-κB and c-Jun N-terminal
kinase (JNK) in liver regeneration.
2. Immediate-EarlyGene
Expressionand SignalTransduction
after PartialHepatectomy
AmonganumberofbiologicalresponsesafterPH,agroupof
genes, so called immediate-early genes, are quickly induced
[6, 7], which lead to the transition of cell cycle from G0 to G1
in hepatocytes. In contrast, some group of genes are upreg-
ulated during the entire period of regenerative responses
[8, 9]. Meanwhile, importance of several proinﬂammatory
cytokines including tumor necrosis factor (TNF)-α and
interleukin (IL)-6 in liver regeneration has been debated
during the last decade [2–4]. It is now accepted that these
cytokines play signiﬁcant roles in the priming and early
stage of liver regeneration after PH. Although expression2 Gastroenterology Research and Practice
of TNF-α and IL-6 is upregulated 1hr after PH, activation
of transcription factor NF-κB and AP-1 and expression
of immediate-early genes, including c-jun, c-fos, and c-
myc, are upregulated within 30min after PH [7]. These
ﬁndings suggest that PH induces very quick biological
responses, which lead to activation of NF-κB and AP-1, and
expression of immediate-early genes. On the other hand,
quick upregulation of urokinase-type plasminogen activator
(u-PA) and uPA receptor (uPAR) is induced in response to
PH[10],implyingsigniﬁcantrolesintheinteractionbetween
u-PAanduPARintheprimingphaseofliverregeneration.u-
PAalsoactivatesseveralgrowthfactors,including hepatocyte
growth factor (HGF) and ligands for epithelial growth factor
receptor(EGFR),whichinducestrongregenerativeresponses
in the liver [11].
Many investigators have proposed that gut microﬂora-
derived lipopolysaccharide (LPS) might trigger the initia-
tion of liver regeneration [12–14]. Upon PH, gut-derived
LPS might activate nonparenchymal liver cells, particularly
Kupﬀer cells, in which NF-κBi sa c t i v a t e d .T h e n ,a c t i v a t e d
Kupﬀer cells release regenerative cytokines, such as TNF-α
and IL-6. IL-6 activates STAT3, resulting in the initiation of
liver regeneration after PH [2]. After the discovery of TLRs,
gut-derived lipopolysaccharide (LPS), a ligand for TLR4, was
reconsideredasatriggeroftheinitiationofliverregeneration
[15, 16].
3. Toll-Like Receptors andLiverRegeneration
Toll-like receptors (TLRs) were originally identiﬁed as
homologs of Drosophila Toll that regulates dorsoventral
embryonic polarity and antifungal immunity [17]. TLRs
facilitate innate immune responses for the host defense
against microorganisms by recognizing pathogen-associated
molecular patterns (PAMPs) [18]. In addition, endogenous
components derived from dying host cells, termed damage-
associated molecular patterns (DAMPs), can bind and acti-
vate TLRs [19, 20]. After the stimulation with corresponding
ligands, TLRs relay signals via myeloid diﬀerentiation factor
(MyD) 88, a common signal adaptor molecule shared by
the receptor for IL-1 and IL-18, and all members of TLRs
except for TLR3 [18]. This signal transduction leads to
activation of NF-κB and results in the production of various
proinﬂammatory cytokines, including TNF-α and IL-6. The
MyD88-dependent pathway also activates p38 and c-Jun N-
terminal kinase (JNK) as well. The TLR/MyD88-mediated
biological events are reminiscent of those observations in
liver regeneration after PH. We and others have investigated
theroleofTLR/MyD88-mediatedsignaltransductioninliver
regeneration after PH [15, 16]. Both studies demonstrated
that in MyD88-deﬁcient mice, induction of immediate-
early genes, including c-fos, c-jun, JunB, and c-myc, was
greatly diminished [15], and NF-κBa c t i v a t i o ni nK u p ﬀer
c e l l sw a sa l s os u b n o r m a la f t e rP H .P r o d u c t i o no fI L - 6a n d
TNF-α and phosphorylation of STAT-3 were completely
suppressed in MyD88-deﬁcient mice after PH [15, 16].
However,thesestudiesshowedcontradictoryrolesofMyD88
in the regenerative response of hepatocytes after PH. DNA
synthesis in hepatocytes signiﬁcantly delayed in the early
phase of liver regeneration in our investigation [15]i m p l i e s
the signiﬁcant role of MyD88-dependent signaling in the
early and priming phase of liver regeneration. Meanwhile,
the MyD88-deﬁcient mice showed no delay in hepatocyte
replication in the other report [16]. To discuss this discrep-
ancy, we might considerthe breeding condition of animals in
diﬀerent institutions. Recent reports demonstrated that mice
from diﬀerent animal suppliers have diﬀerent composition
of microﬂora in the intestine [21]. In addition, MyD88-
deﬁcient mice are more sensitive to changes in the composi-
tion of microﬂora [22]. Here, we propose that there is a large
contribution of intestinal microﬂora-derived components,
as the ligands for TLRs, to liver regeneration after PH.
The diﬀerences in the composition of gut microﬂora might
lead to the diﬀerent regenerative responses between diﬀerent
institutions. Nowadays, the concept that TNFα,I L - 6 ,a n d
NF-κB are crucial for PH-mediated liver regeneration is
still supported by many investigators. Thus, we conﬁdently
propose the concept that the MyD88-dependent regenerative
response after PH is important for initiating the priming
of liver regeneration. Nevertheless, liver mass was ﬁnally
restored in MyD88-deﬁcient mice compared to WT mice
eveninourexperiment,suggestingthatMyD88-independent
compensatory regenerative processes also contribute to liver
regeneration.
Another interesting ﬁnding is that the intact liver
regeneration is induced in TLR2−/−, TLR4−/− [16], TLR2−/−
TLR4−/−,a n dTLR9−/− mice [15] after PH. This result
suggests that the gut-derived LPS and its receptor TLR4 do
not play a major role in triggering the priming phase of
liver regeneration. In addition, both IL-1 and IL-18 receptor
signalings also use MyD88 as a signal adaptor molecule
[23]. Therefore, possible contribution of IL-1 and IL-18
to the priming of liver regeneration should be considered.
However, Caspase-1−/− mice, which lack the capacity to
convert proform of IL-1β and IL-18 to active form [24, 25],
exhibit normal liver regeneration after PH, suggesting minor
roles of IL-1β and IL-18 in liver regeneration [15]. What
is the crucial trigger of the MyD88-dependent biological
events in the priming of liver regeneration? We propose
that various gut microﬂora-derived components and/or
unidentiﬁed endogenous ligands for TLRs activate multiple
TLRs including TLR2, 4, 5, and 9 that lead to triggering the
priming of liver regeneration after PH. Further investigation
is required for proving this hypothesis.
The studies by others and us suggest that TLR/MyD88
signaling participates in the process of liver regeneration,
especially in the early and priming phase, after PH. However,
deﬁnite TLR ligands responsible for the priming process
are still unknown. Further investigations are required for
addressing this issue. Notably, LPS injection suppresses
liver regeneration after PH, indicating that excessive TLR
signaling inhibits this regenerative process [26]. Thus, the
TLR signaling has double-edge sword-like functions in
liver regeneration, and an appropriate magnitude of TLR
signaling is required for intact liver regeneration.
On the other hand, TLR3 utilizes another adaptor
molecule, TRIF (TIR domain-containing adaptor-inducing
interferon-β). Recently, the role of TLR3 signaling in liverGastroenterology Research and Practice 3
regeneration has been reported [27]. In TLR3−/− mice,
initiation of liver regeneration is shifted to the earlier time
point, suggesting that TLR3 signaling inhibits the initiation
of liver regeneration. This inhibitory eﬀect of TLR3 signaling
is also supported by a previous report that activation of
TLR3 by injection of its ligand, polyinosinic-polycytidylic
acid (poly (I:C)), suppressed liver regeneration after PH
[28]. Interestingly, NF-κBa c t i v a t i o ni nh e p a t o c y t e sw a s
signiﬁcantly suppressed up to 10hrs, but its activation
was relatively prominent in Kupﬀer cells in TLR3−/− mice
after PH. These ﬁndings suggest that after PH, unknown
ligands, probably endogenous ligands for TLR3, activate
NF-κB through Rip1 in hepatocytes that inhibit hepatocyte
replication.
Other components of the innate immune system, com-
plements including C3 and C5, have been reported to
participate in liver regeneration after PH [29]. C3- or
C5-deﬁcient mice exhibited high mortality, liver parenchy-
mal cell damage, and impaired liver regeneration after PH.
NF-κB activation was markedly reduced at 1hr after PH
in C3-deﬁcient mice. Thus, the complement system plays
a signiﬁcant role in the priming phase as well as in the
subsequent proliferative phase during liver regeneration.
4. Roles of NF-κBinL i v e rR eg e n e ratio naf t e r
Partial Hepatectomy
NF-κB is an essential transcription factor for maintaining
liver homeostasis, including cell survival and death [30]. As
NF-κB p65 whole body knockout mice cause the embryonic
death due to an extensive hepatocyte apoptosis, NF-κBp l a y s
a crucial role in preventing hepatocyte apoptosis during liver
development [31].
A very quick increase in NF-κB DNA binding activity
afterPH has been reported in early 1990s [32, 33].We arethe
ﬁrst demonstrating the role of NF-κBi nl i v e rr e g e n e r a t i o n
after PH. We introduced IκB α superrepressor, a potent NF-
κB inhibitor, by adenoviral vectors (Ad-IκBsr) to inhibit NF-
κB activation in the liver [34]. In this study, the rat livers
introducing superrepressor of IκB α (IκBsr) demonstrated
the prominent hepatocyte apoptosis and blunted early
increase in NF-κB DNA binding activity in hepatocytes
during the initial 24hrs after PH, suggesting antiapoptotic
role of NF-κB in hepatocytes after PH. Liver regeneration
wassigniﬁcantlyimpairedinthisstudy.Asimilarexperiment
employing Ad-IκBsr in mice was reported by Yang et
al. [35]. In this paper, overexpression of IκBsr in mouse
livers also inhibited liver regeneration after PH but did
not induce hepatocyte apoptosis. Discrepancy between these
reports might be due to diﬀerent infectious abilities against
adenoviral vectors between rats and mice. This might induce
hepatocyte apoptosis only in rats. Since TNFα is produced in
the early period after PH, this discrepancy also might be due
to diﬀerent sensitivity to TNFα-induced cell death between
rats and mice. Thus, activation of NF-κBi nh e p a t o c y t e si s
important as an antiapoptotic factor, at least in rats, but not
in mice after PH.
A subsequent study further reported the speciﬁc role
of hepatocyte NF-κBi nl i v e rr e g e n e r a t i o na f t e rP H[ 36].
Transgenic mice expressing a hepatocyte-speciﬁc mutant
IκBα exhibited the normal regenerative response and did
not show hepatocyte apoptosis after PH. TNFα treatment
induced prominent apoptosis in these animals. A use of ade-
noviral vector in our study, indeed, possibly made the issue
complicated because adenoviral vectors could infect not only
hepatocytes, but also nonparenchymal liver cells including
Kupﬀer cells. In the study by Maeda et al. [37] to inhibit
NF-κB activation, IKKβ (inhibitor of kappaB kinase β, also
known as IKK2) was inactivated in both hepatocytes and
hematopoietic-derived cells (Kupﬀer cells) by conditional
knockout technique using Mx-1 Cre transgenic mice. These
mice reduced the proliferative response after PH. Taken
together, these ﬁndings suggest that NF-κBa c t i v a t i o ni n
Kupﬀer cells is more important than that in hepatocytes.
In a recent study [38], the modulation of hepatocyte
NF-κB activity by inactivation of IKKβ demonstrated the
controversial results from the studies by Maeda et al.,
[37], Yang et al., [35], and us [34]. Hepatocyte-speciﬁc IKKβ
knockout mice showed that accelerated hepatocyte prolifer-
ation and early NF-κB activation in nonparenchymal liver
cells including Kupﬀer cells were observed. In contrast, a
weak and delayed NF-κB activation in hepatocytes was seen
after PH, suggesting that this IKK and NF-κBa c t i v a t i o n
in hepatocytes might be through IKKα. These ﬁndings
further suggest that IKKα in hepatocytes is crucial in
liver regeneration after PH. Addressing this issue, further
investigationisneeded.JNKactivationinhepatocyte-speciﬁc
IKKβ knockout mice is prolonged in the liver after PH
[38]. Because Cyclin D is a JNK/AP-1 target gene, a
strong and sustained JNK activation could be involved in
the accelerated liver regeneration by inducing Cyclin D
expression in hepatocyte-speciﬁc IKKβ knockout mice. This
study also examined pharmacological inhibition of IKKβ,
which enables to inhibit IKKβ activity in both hepatocytes
and nonparenchymal cells. This treatment had little eﬀect on
the regenerative process [38], which corroborates the results
from Chaisson et al. [36], but it does not support the results
from Maeda et al., Yang et al., and us; NF-κBi nK u p ﬀer cells
is critical in liver regeneration.
The crosstalk between NF-κB and JNK in the liver after
PH has been demonstrated in the study using Gadd45β
(growth arrest and DNA-damage-inducible gene 45β), an
NF-κB target gene, knockout mice [39]. Gadd45β−/− mice
exhibited decreased hepatocyte proliferation and increased
programmed cell death during liver regeneration, in which
JNK activity was increased and sustained. This study further
supports the concept that an appropriate activation of NF-
κB in hepatocytes is important for liver regeneration by
regulating JNK activity through Gadd45β. This issue will be
discussed below.
It is now almost acceptable that the activation of NF-κB
in Kupﬀer cells is crucial for intact liver regeneration after
PH, especially for the priming phase [3]. Activated NF-κB
conducts sequential production of TNFα and IL-6, each of
which plays a signiﬁcant role in the priming phase of the
regenerative process. Indeed, early activation of NF-κBi n
liver regeneration after PH was demonstrated to primarily
occur in Kupﬀer cells using cis-NF-κB-EGFP transgenic mice4 Gastroenterology Research and Practice
[35]. Moreover, inactivation of NF-κBi nK u p ﬀe rc e l l sa sw e l l
asinhepatocytesimpairedtheproliferativeresponseafterPH
as mentioned above [37].
5.JNKActivationafterPartialHepatectomy
Prompt expression of c-jun and activation of c-Jun N-
terminal kinase (JNK) have been reported after PH as
described above [40, 41]. Fetuses lacking c-jun die at midges-
tation with defects in heart morphogenesis and increased
apoptosis of both hepatoblasts and hematopoietic cells in the
fetal liver [42, 43]. Moreover, mice lacking the JNK kinase
SEK1 exhibit a liver defect similar to c-jun−/− fetus [44, 45].
Roles of the transcription factor AP-1 (activator protein-1),
including c-Jun, as a regulator of cell survival and death are
well summarized in a previous paper [46]. The function of
c-Jun at later stages of liver development or in adult liver
remained to be elucidated.
The role of c-jun during liver regeneration after PH was
ﬁrstreportedbyusingﬂoxedc-junalle(c-junf)micecrossing
with Alfp-cre or Mx-cre transgenic mice [47]. In either
Alfp-cre or Mx-cre-induced conditional c-jun knockout
mice, prominent hepatocyte death and lipid accumulation
in hepatocytes were observed after PH. These mice exhibited
high mortality and impaired liver regeneration. These results
indicate that c-jun is required for hepatocytes regeneration
after PH. Interestingly, c-Jun N-terminal phosphorylation is
n o tr e q u i r e df o rc - J u nf u n c t i o ni nl i v e rr e g e n e r a t i v er e s p o n s e
[47].
Important roles of JNK activation after PH have been
reported [48]. Inhibition of JNK activity in the liver using
a small molecule JNK inhibitor (SP600125) resulted in
reduced c-Jun phosphorylation and AP-1 DNA binding
activity. JNK inhibition suppressed cyclin D1 expression
and delayed hepatocyte proliferation after PH, resulting
in decreased survival but not hepatocyte apoptosis. This
implied that JNK drives the transition of cell cycle from
G0 to G1 transition in hepatocytes and that cyclin D1 is a
crucial target gene of the JNK pathway in liver regeneration.
However, these results were diﬀerent from the data obtained
from the study in which c-jun was genetically inactivated
[47]. Potential explanation for this discrepancy is that JNK
mediates its eﬀects on liver regeneration after PH through
other targets such as ATF2 or JunD [48]. As mentioned
above, c-Jun N-terminal phosphorylation is not required for
regeneration after PH [47], suggesting that increased JNK
activity after PH has other signiﬁcant roles rather than its
ability to phosphorylate c-Jun N-terminal. Two isoforms
of JNK are expressed in the liver; JNK1 and JNK2 [49,
50]. Distinct functions in these JNKs have been reported
[51]. Namely, JNK1 induces cell proliferation with c-Jun
phosphorylation. In contrast, JNK2 suppresses proliferation
bydegradationofc-Jun.SabapathyandWagneralsoreported
an acceleration of liver regeneration in JNK2−/− mice in their
perspective [52].
HGF and EGFR-ligands activate JNK. Mice expressing
an inducible Met mutation by Mx-cre system in the liver
showed blunted c-jun phosphorylation around 48h after PH
and a great suppression of Erk1/2 phosphorylation during
the entire regeneration process [53]. Hepatocyte-speciﬁc
EGFR deletion resulted in reduced cyclin D1 expression
and delayed hepatocyte proliferation after PH. Surprisingly,
this observation was accompanied by sustained activation
of c-Jun and reduced NF-κB DNA binding activity [54].
This prolonged c-Jun activation after PH in the hepatocyte-
speciﬁc EGFR-deleted mice might be independent of EGFR-
mediated JNK activation, or there might be unknown
negative regulatory mechanism on JNK/c-Jun activation in
the EGFR signaling cascade. Nevertheless, it is suggested that
prolonged activation of c-Jun inhibits liver regeneration after
PH. Prolonged activation of JNK after PH has also been
observed in Gadd45β −/− mice as mentioned above [39].
Why does prolonged JNK activation suppress liver regenera-
tion after PH? Notably, a genetical ablation of JNK2 prevents
impaired liver regeneration and increased hepatocyte cell
death in Gadd45β −/− mice after PH. Although it is obvious
that JNK pathway directly induces cyclin D1 upregulation
to contribute to hepatocyte proliferation [39], however,
prolonged JNK activation hampers liver regeneration after
PH, at least, by enhancing programmed cell death.
TGF-β-activated kinase (TAK)-1 is a crucial component
for activating both NF-κB and JNK. An adenoviral over-
expression of dominant negative in the liver accelerated
the proliferative response after PH [55]. This might be
explained by the inhibitory role of IKKβ and JNK2 in liver
regeneration in previous studies [38, 52]. An appropriate
crosstalk between JNK and NF-κBi sc r i t i c a lf o ri n t a c tl i v e r
regeneration after PH. An opposing role of NF-κBa n d
JNK in hepatocarcinogenesis has been proposed. Loss of
NF-κB activity in hepatocytes increases the sensitivity to
hepatocarcinogenesis with increased JNK activation [37, 56–
58]whileJNK1knockoutmiceexhibitdecreasedcarcinogen-
esis after N-nitrosodiethylamine administration [59]. The
mutual crosstalk between the NF-κBa n dJ N Kh a sb e e nw e l l
documented in the previous reviews [60, 61].
In summary, the transient upregulation of the two
downstream targets NF-κB and JNK in TLR/MyD88 and
TNFR signaling is strictly organized in Kupﬀer cells and hep-
atocytes upon PH, which leads to normal liver regeneration
(Figure 1).
6. ClinicalIssues in LiverRegeneration
Understanding the mechanism of liver regeneration is
important for managing several clinical conditions, such as
acute liver failure and impaired hepatic functions after liver
transplantation. An issue concerning small-for-size grafts in
liver transplantation is a well-known clinical subject. An
experiment using small-for-size graft in rats revealed that
suppressed AP-1 DNA binding activity and reduced cyclin
D1 expression resulted in impaired liver regeneration. This
was attenuated by administration of a radical scavenger [62].
Impaired liver regeneration in patients with NASH (nonal-
coholic steatohepatitis) or NAFLD (nonalcoholic fatty liver
disease) is also a major clinical issue. Animal experiments
revealed that impaired liver regeneration with suppressed
NF-κB DNA binding activity and delayed and prolonged
c-jun expression after PH in ob/ob mice [63]. MicroarrayGastroenterology Research and Practice 5
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Figure 1: Signal transduction pathways during the priming phase of liver regeneration. Interactions between Kupﬀer cells and hepatocytes
are also illustrated while other nonparenchymal cells are also possibly involved. AP-1, activator protein; C3aR, activated compliment 3
receptor; C5aR, activated compliment 5 receptor; Gadd45β, growth arrest and DNA-damage-inducible gene 45β; IKK, inhibitor of nuclear
factor κB kinase; IL-6, interleukin-6; JAK, Janus-associated kinase; JNK, c-jun N-terminal kinase; MKK7, mitogen-activated protein kinase
7; MyD88, myeloid diﬀerentiation factor 88; NEMO, nuclear factor κB essential modulator; RIP, receptor interacting protein; TLR, toll-like
receptor; TNFα, tumor necrosis factor α; TRIF, TIR-domain containing adaptor inducing interferon-β.
analysis in the patient livers with NASH revealed that mRNA
expression of transcription factors such as v-Jun (oncogenic
isoform of c-Jun) was signiﬁcantly suppressed compared
with nonobese control patients even without liver resection
[64]. However, the most critical issue in clinical situation
is impaired liver regeneration in patients with advanced
liver ﬁbrosis. A number of factors including deposition of
excessiveamount ofextracellularmatrix, existenceof contin-
uousinﬂammation,transformationofsinusoidalendothelial
cells and hepatic stellate cells, and decreased portal blood
ﬂow may aﬀect the regenerative ability in the ﬁbrotic livers.
In addition, increased JNK activity, as observed in animal
models during ﬁbrogenesis [65], may also account for the
impaired regenerative process in these patients.
7. Summary
The ligands for TLRs are a strong candidate for triggering
the initiation of liver regeneration. However, discovery of the
real trigger which initiates liver regeneration is a challenging
assignment for hepatologists because multiple ligands and
multiple TLRs could contribute to this process. In addition,
understanding of the interaction between the two major
transcription factors; NF-κB and AP-1 (such as c-Jun), and
theregulationofJNKactivitybyNF-κBseemstobecriticalto
elucidate the well-orchestrated process. Further investigation
of distinct roles between these factors in hepatocytes and
nonparenchymal cells should be required employing cell-
speciﬁc gene manipulation techniques. The management
of the impaired balance between these factors in non-
parenchymal cells and hepatocytes may provide insight
into developing new strategies for inappropriate hepatic
regenerativeresponseinpatientswithchronicandacuteliver
diseases.
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